Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Rare Diseases and Disorders
Study Phase : Discovery
Recipient : KBio
Deal Size : Undisclosed
Deal Type : Partnership
KBio Announces Strategic Partnership with ZabBio to Discover and Develop Antibody Therapeutics
Details : Under the terms of the agreement, KBio will have development rights to select assets within ZabBio’s current pipeline of antibody therapies – including a late-stage preclinical anti-fungal mAb – as well as future products discovered under the colla...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 13, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Discovery
Recipient : KBio
Deal Size : Undisclosed
Deal Type : Partnership